How Medical Equipment Companies Are Valued
Medical equipment valuation spans durable medical equipment (DME) suppliers, medical device distributors, and equipment service companies. Our database of 174 transactions shows a median earnings multiple of 8.59x across all deal sizes, with SMB deals ($5M-$25M) averaging 5.4x and mid-market deals ($25M-$100M) reaching 6.3x. The wide range reflects the enormous difference between commodity equipment resale and businesses with proprietary products or recurring consumable revenue.
Revenue Model Drives the Multiple
Recurring consumables and supplies are the highest-value revenue stream. A medical equipment company where 50%+ of revenue comes from recurring consumable orders (respiratory supplies, wound care, infusion supplies) commands platform-tier earnings multiples because this revenue is predictable, high-margin, and has strong retention. Each patient on service represents an annuity stream.
Equipment distribution with service contracts generates premium value when the company holds exclusive or semi-exclusive territory rights from manufacturers. Distribution relationships that took 10+ years to build are difficult for competitors to replicate and represent real intangible value.
Pure equipment resale without recurring revenue or service contracts trades at the low end (platform-tier earnings multiples) because it's essentially a distribution business with limited differentiation. Margins tend to be thinner and customer relationships less sticky.
Key Value Drivers for Medical Equipment
Payer mix and reimbursement stability are critical for DME companies. Medicare and Medicaid reimbursement rates directly impact revenue and margins. Companies with diversified payer mix (Medicare, commercial insurance, private pay, VA) are more resilient to reimbursement cuts. Competitive bidding program exposure remains a key risk factor.
GPO and IDN relationships (Group Purchasing Organizations and Integrated Delivery Networks) determine access to hospital and health system purchasing. Companies with established GPO contracts (Vizient, Premier, HealthTrust) have competitive moats that take years to build. Losing GPO access can eliminate entire customer segments overnight.
Regulatory compliance and accreditation serve as barriers to entry. FDA registration, state licensing, accreditation (ACHC, Joint Commission), and Medicare/Medicaid supplier enrollment are all required to operate. Companies with clean compliance histories and current accreditations are worth more because obtaining these credentials is a 12-24 month process.
Service and repair capabilities create ongoing customer touchpoints and recurring revenue. Medical equipment companies that service what they sell, especially biomedical equipment, imaging systems, or lab equipment, generate high-margin service revenue that buyers value at premium multiples.
What Decreases Medical Equipment Value
Medicare reimbursement dependency without payer diversification creates regulatory risk. CMS rate changes can eliminate margins overnight. DME companies with 70%+ Medicare revenue are more volatile and command lower multiples than those with balanced payer mix.
Manufacturer concentration where 50%+ of revenue comes from distributing a single manufacturer's products creates supply risk. If the manufacturer changes distribution strategy or is acquired, the business faces existential threat. Diversified product lines across multiple manufacturers reduce this risk.